Treating MCF-7 and MDA-MB-468 breast cancer cells with berberine at a concentration of 15 μM and subjecting them to various doses of X-rays (ranging from 1 to 4 Gy), resulted in a decrease in RAD51 protein levels compared to control cells. This evidence concerns the gene RAD51 and breast cancer.